Insider Transactions in Q1 2022 at Invitae Corp (NVTA)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 14
2022
|
Kenneth D. Knight Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,358
-0.73%
|
$14,148
$6.69 P/Share
|
|
Mar 14
2022
|
Robert L Nussbaum Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
19,588
-7.51%
|
$117,528
$6.69 P/Share
|
|
Mar 14
2022
|
Yafei Wen Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,289
-2.35%
|
$19,734
$6.69 P/Share
|
|
Mar 14
2022
|
Thomas Brida |
SELL
Open market or private sale
|
Direct |
17,987
-7.26%
|
$107,922
$6.69 P/Share
|
|
Mar 14
2022
|
Sean E George Director |
SELL
Open market or private sale
|
Direct |
31,389
-3.72%
|
$188,334
$6.69 P/Share
|
|
Mar 12
2022
|
Kenneth D. Knight Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,705
+4.33%
|
-
|
|
Mar 12
2022
|
Robert L Nussbaum Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,705
+5.34%
|
-
|
|
Mar 12
2022
|
Yafei Wen Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,705
+9.52%
|
-
|
|
Mar 12
2022
|
Thomas Brida |
BUY
Grant, award, or other acquisition
|
Direct |
14,705
+5.6%
|
-
|
|
Mar 12
2022
|
Sean E George Director |
BUY
Grant, award, or other acquisition
|
Direct |
44,117
+4.97%
|
-
|